ProtModification Btrc ---| Ctnnb1

URN urn:agi-ProtModification:inout-urn:agi-llid:8945:out-urn:agi-llid:1499::unknown
References 7
Connectivity 2
Effect unknown

TextRef info:pmid/18806787#abs:4
MedLine Reference 18806787:3
Sentence Whereas the well-established beta-catenin E3 ubiquitin ligase component beta-TrCP ubiquitylates only phosphorylated beta-catenin, Jade-1 ubiquitylates both phosphorylated and non-phosphorylated beta-catenin and therefore regulates canonical Wnt signalling in both Wnt-off and Wnt-on phases.

TextRef info:pmid/16809773#cont:319
MedLine Reference 16809773:10318
Sentence The F-box protein beta-TrCP associateswith phosphorylated beta-catenin and regulates its activity in thecell.
Journal Mol. Cell. Biol
Journal Reference v26 i14 p5373
Journal Link http://mcb.asm.org/cgi/content/full/26/14/5373

TextRef info:pmid/10228155#cont:122
MedLine Reference 10228155:10121
Sentence Facilitation of eta-catenin ubiquitination in vivo . ( A ) Promotion of eta-catenin ubiquitination by FWD1.
CellLineName 293T
Journal EMBO
Journal Reference v18 i9 p2401
Journal Link http://emboj.oupjournals.org/cgi/content/full/18/9/2401

TextRef info:pmid/16510874#cont:22
MedLine Reference 16510874:10021
Sentence The phosphorylated ß-cat is then ubiquitinated by ßTrCP and destroyed by proteasome-mediated proteolysis.
Tissue epithelia
CellType Hematopoietic Stem
Organ gastric
Journal Genes & Dev
Journal Reference v20 i5 p586
Journal Link http://www.genesdev.org/cgi/content/full/20/5/586

TextRef info:pmid/16177058#cont:23
MedLine Reference 16177058:10022
Sentence Substrate phospho-I?B-a and phospho-ß-catenin are normally ubiquitinated by a specific ubiquitin ligase complex designated E3-SCF ß-TrCP ( 2 , 3 ).
Tissue epithelia
Organism Homo sapiens
Journal J. Immunol
Journal Reference v175 i7 p4194
Journal Link http://www.jimmunol.org/cgi/content/full/175/7/4194

TextRef info:pmid/17855653#cont:101
MedLine Reference 17855653:10100
Sentence Because the phosphorylation of ß-catenin by GSK-3ß and its subsequent association with ß-TrCP leads to ß-catenin degradation (Winston et al., 1999 ), we examined whether decursin-mediated inhibition of the Wnt/ß-catenin pathway requires GSK-3ß activity.
Journal Mol. Pharm
Journal Reference v72 i6 p1599
Journal Link http://molpharm.aspetjournals.org/cgi/content/full/72/6/1599

MedLine Reference 160100062:10070
Sentence Thus, the identification of SCF ß-Trcp as the enzyme that ubiquitinates ß-catenin is expected to have a significant impact on both cancer biology and clinical oncology.
Journal Oncogene
Journal Reference v18 i4 p1202653
Journal Link http://www.nature.com/onc/journal/v18/n4/full/1202653a.html